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ABSTRACT
Background/Aims: It is unclear whether patients with irritable bowel syndrome (IBS) require a high dose of sedatives during colonosco-
py. In this study, we investigated the pre-procedural anxiety levels, sedative consumption, procedure times, complications, and patient’s 
satisfaction between patients with IBS and controls for ambulatory colonoscopy under sedation. 
Materials and Methods: Rome III criteria were used in the diagnosis of IBS. Anxiety levels were measured using Spielberger’s State-Trait 
Anxiety Inventory (STAI) and Beck Anxiety Inventory (BAI). Patients received a fixed dose of midazolam (0.02 mg/kg), fentanyl (1 μg/kg), 
ketamine (0.3 mg/kg), and incremental doses of propofol under sedation protocol. Demographic data, heart rate, blood pressure, and 
oxygen saturation were measured. Procedure times, recovery and discharge times, drug doses used, complications associated with the 
sedation, and patient’s satisfaction scores were also recorded. 
Results: The mean Trait (p=0.015), State (p=0.029), Beck anxiety scores (p=0.018), the incidence of disruptive movements (p=0.044), and 
the amount of propofol (p=0. 024) used were significantly higher in patients with IBS. There was a decline in mean systolic blood pressure 
at the 6th minute in patients with IBS (p=0.026). No association was found between the sedative requirement and the anxiety scores.  
Conclusion: Patients with IBS who underwent elective colonoscopy procedures expressed higher pre-procedural anxiety scores, re-
quired more propofol consumption, and experienced more disruptive movements compared with controls. On the contrary, the increased 
propofol consumption was not associated with the increased pre-procedural anxiety scores.
Keywords: Colonoscopy, irritable bowel syndrome, sedation, anxiety
INTRODUCTION
Irritable bowel syndrome (IBS) is associated with abdom-
inal pain, discomfort, altered bowel habits, and change in 
stool consistency without an organic disorder (1,2). Most 
patients with IBS have poor quality of life with psychiat-
ric co-morbidities, such as anxiety, depression, and mood 
disorders (3-5). Moreover, several studies have shown 
that compared with healthy subjects, patients with IBS 
have higher anxiety levels (6-8).
Colonoscopy is commonly performed in the differential 
diagnosis of IBS, and some gastroenterologists believe 
that patients with IBS remain more uncomfortable or re-
quire more sedation and analgesics during colonoscopy 
(9-11). However, we could not find a prospective study 
that investigated the anxiety levels, anesthetic consump-
tion, recovery profiles, complications, and satisfaction in 
patients with IBS that underwent elective colonoscopy 
under sedation.
In this study, we aimed to compare the pre-procedural 
anxiety levels, propofol consumption, recovery profiles, 
complications, and patient’s satisfaction between pa-
tients with IBS and controls undergoing ambulatory colo-
noscopy under sedation.
MATERIALS AND METHODS
This study was performed between May 2013 and Au-
gust 2015 following ethical approval (Başkent University 
Institutional Review Board, Project No: KA13/95, May 23, 
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2013) in a double-blind fashion. Informed consent was 
obtained from each patient. The anesthesiologist who 
performed the sedation procedure and collected the data 
including demographic characteristics, hemodynamic 
status, complications, procedure times, and drug doses 
used, and the patients were blinded to the groups. The 
gastroenterologist evaluated all the patients scheduled 
for elective colonoscopy for the presence of IBS accord-
ing to the Rome III criteria (12). Additionally, blood tests 
and stool analysis were performed to exclude organic dis-
eases in these patients. Patients not belonging to the age 
group of 18-75 years, American Society of Anesthesiol-
ogy (ASA) physical status class ≥3, not having a previous 
history of colonoscopy, anesthesia, or sedation for past 7 
days, psychiatric disorders, drug addiction, known allergy 
to medications used in the study protocol, and inability 
to provide informed consent were excluded. All patients 
were informed about the procedure and the protocol, 
risks and complications of sedoanalgesia via a standard 
face-to-face interview with the gastroenterologist and 
anesthesiologist separately.
All patients went through the standard colon preparation 
protocol the day before colonoscopy. On the day of the 
procedure, state and trait anxiety levels of the patients 
were measured by the gastroenterologist using the Spiel-
berger’s state-trait anxiety inventory (STAI) and Beck 
anxiety inventory (BAI) (13,14). Colonoscopies were per-
formed by the same gastroenterologist using the same 
colonoscope (Fujinon EC-450WL5, Fuji Photo Optical Co. 
Ltd., Saitama, Japan) in all the patients.
In the gastroenterology unit, after recording demograph-
ic data, an intravenous catheter was inserted in the arm, 
and 0.9% sodium chloride solution was administered 
intravenously. All patients were continuously monitored 
for heart rate, systolic blood pressure (SBP), diastol-
ic blood pressures (DBP), heart rate (HR), oxygen satu-
ration (SpO2), and sedation levels before administration 
of anesthetic medicines every 2 minutes for the first 10 
minutes and every 5 minutes thereafter. Supplemental 
oxygen (3 L/min) was provided via a facemask through-
out the procedure. Sedation levels were monitored using 
the Ramsay sedation scale (RSS). Recovery and discharge 
criteria were determined based on the RSS and Modified 
Post Anesthesia Discharge Scoring System (MPADSS), 
respectively (15,16). The procedure times were deter-
mined as follows:
• induction time=time from first drug administration to 
the start of procedure, 
• cecum intubation time=time from start of procedure 
until colonoscope insertion into the cecum, 
• duration of colonoscopy=time from start of proce-
dure until colonoscope removal, 
• recovery time=time from colonoscope removal until 
the patient reached an RSS of 2,
• discharge time=time from colonoscope removal to 
achieving MPADSS≥9.
In both groups, patients received a fixed dose of intra-
venous 0.02 mg/kg midazolam (Midazolam; Zolamid, 
Defarma, Turkey), 1 μ/kg fentanyl (Talinat, Vem, Turkey), 
0.3 mg/kg ketamine (Ketalar, Pfizer, USA), and incre-
mental doses of propofol (Propofol-Lipuro, Braun, Ger-
many) to achieve a RSS of 3-4. Sedation was maintained 
using 10-20 mg of additional propofol doses at RSS of 
3-4 throughout the procedure. Disruptive movements 
during the procedure were recorded. At the end of the 
procedure, verbal commands (open your eyes) were re-
peated at 1-minute intervals until the patient respond-
ed. Subsequently, the patients were transported to the 
post anesthesia care unit (PACU) when the RSSs were 2. 
In the PACU, the patients were monitored for vital signs, 
postoperative nausea and vomiting, postoperative pain, 
and psychological reactions such as hallucination. The 
patients were discharged upon achieving MPADS≥9. 
Procedure times and anesthetic consumption were also 
recorded.
The jaw thrust maneuver was applied when apnea oc-
curred for more than 15 seconds. Mask ventilation was 
used when SpO2 fell below 90% and the patient was still 
apneic. A drop of >20% of the patient’s SBP or a drop to 
a value of <90 mm Hg was defined as hypotension and 
was treated with an intravenous infusion of 0.9% sodi-
um chloride solution. Hypertension was defined as an 
increase of >20% of the patient’s baseline SBP. A drop 
in HR to <50 beats/min was defined as bradycardia and 
was treated using intravenous atropine (atropine sulfate, 
Galen, Turkey). Any need for jaw thrust or mask ventila-
tion and any other adverse side effects of sedation were 
recorded.
All patients were asked whether they had experienced 
unpleasant dreams or hallucinations and to rate their 
satisfaction with the sedation using the 3-point scale 
(0=satisfactory; 1=less than satisfactory; and 2=unsatis-
factory). They were also questioned regarding their will-
ingness to receive the same sedation protocol if needed 
in the future at discharge and 24 hours after the proce-
dure (by telephone).
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Statistical analysis
All data were analyzed using the Statistical Package for 
the Social Sciences 20.0 for Windows (IBM Corp.; Ar-
monk, NY, USA). Normally distributed data, which was 
confirmed using the Kolmogorov-Smirnov test, was an-
alyzed using Student’s t-test; the Chi square test was 
used for comparison of categorical data. p<0.05 was con-
sidered statistically significant. Independent from groups, 
the Pearson correlation analysis was used to determine 
the associations between propofol requirement and anx-
iety scores.
The sample size was calculated based on the propofol 
consumption of two groups, which was the main endpoint 
of our study. In a previous trial, we found that the average 
propofol consumption with midazolam-fentanyl-ket-
amine based sedation was 70±22.5 mg (17). Assuming a 
25% difference of propofol requirement, at least 35 pa-
tients were required in each group with an alpha value of 
0.05, beta value of 0.95, and an effect size of 87% with a 
power of 95%. We planned to include 40 patients in each 
group because we assessed multiple parameters.
RESULTS
In total, 126 potential participants scheduled for elective 
colonoscopy under sedation were assessed for eligibili-
ty. Nineteen of these refused to give informed consent, 
27 refused to complete the anxiety inventories; in 4 pa-
tients, colonoscopy was aborted because of inadequate 
bowel preparation. Consequently, 76 patients were in-
cluded in this study. Indications for colonoscopy were 
gastrointestinal complaints, including constipation and 
diarrhea (n=54) and screening for colorectal malignan-
cy (n=17) and anemia (n=5). Patient characteristics were 
comparable between groups (Table 1). In the IBS group, 
the mean trait anxiety scores (p=0.015), state anxiety 
scores (p=0.029), Beck anxiety scores (p=0.018), and 
the amount of propofol (p=0.024) used were significant-
ly higher compared with the non-IBS group. Procedure 
times and the amount of midazolam, fentanyl, and ket-
amine were comparable between the groups (Table 2).
Except the decline in mean SBP at the sixth minute in 
the IBS group (p=0.026), hemodynamic data including 
DBP, HR, and SpO2 were not significantly different be-
tween the groups. Bradycardia occurred in one and four 
patients in the non-IBS and IBS groups, respectively. The 
incidence of desaturation (SpO2<90) and the need for 
jaw thrust maneuver or mask ventilation were not differ-
ent between the groups. In the IBS group, the incidence 
of unintended movements was significantly higher than 
that in the IBS group (8 vs 2), particularly before cecum 
intubation (p=0.044). No patient experienced unpleasant 
dreams or hallucination (Table 3). All patients were satis-
fied with their sedation protocol and expressed willing-
ness to receive the same sedation protocol again in the 
future.
Independent from groups, the Pearson correlation analy-
sis showed no association between propofol requirement 
and the state anxiety scores, trait anxiety scores, and 
Beck anxiety scores (Figure 1).
 Non-IBS  
 group IBS group 
 (n=39) (n=37)
Demographic characteristics (mean±SD or number)
Age (years) 60.1±10.6 61.1±10.4
BMI (kg/m2) 27.0±3.2 26.8±3.3
Gender (M/F) 19/20 19/18
ASA status (I/II) 11/28 14/23
Educational level
<High school 7 5
High school 12 14
University 20 18
IBS: irritable bowel syndrome; BMI: body mass index; M: male; F: female; 
ASA: American Society of Anesthesiologists; SD: standard deviation
Table 1. Endoscopic and histopathologic findings of CD 
patients
Figure 1. There was no correlation between the propofol requirement and the state, trait, and Beck anxiety scores
a b c
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DISCUSSION
The present study showed that IBS patients reported 
greater pre-procedural anxiety scores, required more 
propofol, and experienced more disruptive movements 
than the non-IBS patients during colonoscopy under se-
dation. However, we observed that the increased propo-
fol requirement was not associated with the increased 
pre-procedural anxiety scores.
Irritable bowel syndrome is a common gastrointestinal 
disorder characterized by gastrointestinal symptoms, 
such as abdominal pain, discomfort, altered bowel hab-
its, and stool consistency in the absence of an organic 
disease as diagnosed by routine physical examination, 
laboratory tests, and colonoscopy (1). Its prevalence is 
approximately 10%-20% in the general population (2). 
Although the etiology is unclear, several studies have 
shown that psychological, social, and environmental 
factors are important and that approximately greater 
than 50%-60% patients with IBS have major psycho-
logical problems, including anxiety, depression, soma-
tization, and mood disorders (3-7). A meta-analysis 
similarly reported that IBS patients had significantly 
higher anxiety levels than healthy controls (8). Higher 
anxiety levels in patients with IBS can also be related to 
their perception of colonoscopy as reported in previous 
studies (9). Although, a large number of these patients 
undergo elective colonoscopy to exclude any organic 
diseases in IBS, to our knowledge, this is the first study 
 Non-IBS  
 group IBS group 
 (n=39) (n=37) p
Bradycardia 1 (2.56%) 4 (10.8%) 0.194
SpO2<90 4 (10.2%) 7 (18.9%) 0.341
Jaw thrust maneuver 4 (10.2%) 7 (18.9%) 0.341
Mask ventilation 0 (0%) 2 (5.4%) 0.234
Disruptive movements 2 (5.12%) 8 (21.6%)* 0.044
Post procedure pain 17 (43.5%) 22 (59.4%) 0.179
Vomiting during colonoscopy 0 0 -
Postoperative vomiting
(At discharge/after 24 hours) 0/0 0/0 -
Unpleasant dreaming
(At discharge/after 24 hours) 0/0 0/0 -
Hallucinations
(At discharge/after 24 hours) 0/0 0/0 -
IBS: irritable bowel syndrome; SpO2: oxygen saturation
Table 3. Complications associated with sedation during and 
after colonoscopy
  Non-IBS group IBS group 
  (n=39) (n=37)
Anxiety scores (mean±SD/median-IQR)  
 STAI-trait anxiety inventory 38.6±6.2/39.0±10.0 42.1±6.0±41.0±7.0 *
 STAI-state anxiety inventory 34.8±9.0/34.0±16.0 39.6±9.9/40.0±15.5 **
 Beck anxiety inventory 11.2±5.0/11.0±6 14.5±6.9/14±8.5***
Procedure time (minutes) (mean±SD/median-IQR)  
 Induction 2.3±0.6/2.1-0.5 2.5±0.7/2.5-1.1
 Cecum intubation 5.7±2.4/5.0-3.0 6.0±1.7/6.0-3.0
 Duration of colonoscopy 11.7±3.9/10-6.0 11.7±3.2/10.0-6.0
Recovery and discharge times (minutes) (mean±SD/median-IQR)  
 Recovery 4.1±1.3/4.0-2.0 4.4±1.5/4.5-2.2
 Discharge 14.7±2.7/14.5-3.5 15.5±3.1/15.5-4.2
Total drug doses used (mean±SD/median-IQR)  
 Midazolam (mg) 1.5±0.2/1.6-0.5 1.8±2.2/1.5-0.4
 Fentanyl (μg) 77.3±11.4/80.0-20.0 75.5±16.8/70.0-15.0
 Ketamine (mg) 21.5±2.8/21-6.0 21.2±2.7/21-6.0
 Propofol (mg) 71.2±18.9/70.0-20.0 80.5±15.9/80.0-20.0****
Variables are expressed as mean±SD and median with IQR; MPADS≥9, *p=0.015, **p=0.029, ***p= 0.018, ****p=0.024
IBS: irritable bowel syndrome; SD: standard deviation; IQR: inter-quartile range; STAI: state-trait anxiety inventory; MPADS: modified post anesthesia 
discharge score
Table 2. Anxiety scores, procedure times, and total drug doses used
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that investigated the pre-procedural anxiety levels, an-
esthetic requirements, complications, and patient satis-
faction in patients with IBS who underwent colonosco-
py. Our study revealed that patients with IBS scheduled 
for elective colonoscopy reported significantly higher 
pre-procedural anxiety scores than non-IBS patients. 
These results were consistent with the earlier studies, 
which reported that anxiety levels of patients with IBS 
were higher than those in healthy controls (6-8).
The increase in preoperative anxiety level is believed 
to lead to increased perioperative anesthetic require-
ment. Nevertheless, previous studies investigating the 
relationship between pre-procedural anxiety levels and 
anesthetic requirement revealed conflicting results. 
Maranets and Kain (18) investigated the association be-
tween baseline anxiety and propofol requirement for the 
induction and maintenance of alfentanil-N2O-propo-
fol-based general anesthesia in 57 patients who under-
went bilateral laparoscopic tubal ligation. It was found 
that not state anxiety but trait anxiety is associated 
with intraoperative anesthetic requirement. In 100 pa-
tients who underwent total thyroidectomy, Kil et al. 
(19) reported that patients with high state-trait anxiety 
scores required more propofol requirement during light 
to moderate levels of sedation, and that propofol re-
quirement was associated with trait anxiety during deep 
sedation. Osborn et al. (20) investigated the effects of 
anxiety on 25 patients who underwent molar extraction 
under midazolam-fentanyl-propofol based sedation 
and found that patients with high state and trait anxiety 
required more propofol, whereas those with high trait 
anxiety had more intraoperative movements. Hong et 
al. (21) investigated the effects of baseline anxiety on 
propofol requirement and recovery profile in 150 pa-
tients who underwent oocyte retrieval under conscious 
sedation with propofol and reported that patients with 
high anxiety required higher propofol dose and were as-
sociated with delayed induction time. In all these studies, 
there are differences in the anesthetic techniques, drug 
combinations, anxiety assessment tools, and sedation 
levels. Moreover, there are also procedural differences 
that result in different degrees of painful stimulation. 
Chung et al. (22) investigated the effects of anxiety on 
sedative requirement in 135 patients undergoing colo-
noscopy and found that there was no relationship be-
tween the level of pre-procedural anxiety and sedative 
requirement or recovery characteristics. Our findings are 
consistent with the study of Chung et al. (22), suggest-
ing that there are other possible mechanisms leading to 
an increase in propofol requirement in IBS patients.
The regulation of the gastrointestinal tract function is 
under the control of different complex systems. The 
network, which connects the gastrointestinal tract and 
the central nervous system, is also known as the brain-
gut pathway and connects emotional and cognitive 
areas in the central nervous system and is thought to 
be involved in IBS (7,8). Anxiety and/or depression can 
change the regulatory functions of the autonomic ner-
vous system and neuroendocrine centers, which trans-
fer the message to the enteric nervous system resulting 
in an alteration in gastrointestinal hormones, mucosal 
blood flow, and intestinal motility. These changes may 
influence visceral sensation, intestinal movement, and 
endocrine function leading to the symptoms in patients 
with IBS (6,8). It has been documented that increased 
sensitivity to bowel stretching in patients with IBS leads 
to an increase in pain experienced during colonosco-
py compared with non-İBS patients (10). Therefore, 
all these features may offer disadvantages in patients 
with IBS wherein the most unwanted effects are pain, 
hemodynamic derangement, and vasovagal reactions, 
possibly because of distension of the colon and stretch-
ing of the mesentery during colonoscopy. In this study, 
vasovagal reactions were observed in 1 and 4 patients 
in the nonIBS and IBS groups, respectively, which were 
not significant; fluctuations in hemodynamic param-
eters were not significantly different among groups, 
except the decline in mean SBP at the sixth minute in 
the IBS group. A possible explanation for this decrease 
is the higher propofol dosage required before cecum 
intubation in this group. Compared with the non-IBS 
group, more patients in the IBS group (8 vs 2) required 
additional rescue dose of propofol immediately before 
cecum intubation because of disruptive movements in 
our study. These findings are also consistent with those 
of authors who pointed out that patients with IBS have 
increased visceral sensitivity to rectal or colonic disten-
tion and decreased threshold for pain (23-26).
In our study, there was no difference between the groups 
in procedure times, including recovery and discharge, and 
all the patients in both groups expressed their satisfac-
tion as satisfactory with willingness to receive the same 
sedation regimen again in the future. Adequate amnesia, 
analgesia, and sedation provided by an anesthesiologist 
using a practical scale and midazolam-fentanyl-ket-
amine-propofol combination might be the reason of high 
satisfaction scores in both groups.
Our study has several limitations. First, the measures 
used in anxiety assessments were based on patient’s 
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self-reported subjective scoring systems rather than ob-
jective indicators. Therefore, we used both the Spielberg-
er’s STAI and Beck anxiety inventories to compare our re-
sults with previous studies. Second, the sedation protocol 
used included a fixed dose of midazolam, fentanyl, and 
ketamine, and incremental doses of propofol to achieve 
and maintain adequate sedation during colonoscopy. The 
variability in either group might be decreased using this 
combination, and a greater difference might have been 
detected between the groups if we had used only propo-
fol in the sedation protocol. Third, we used a per body 
weight dosage for midazolam, fentanyl, and ketamine, 
which might be unreliable because of inter-individual 
variability (20).
In conclusion, in adult patients who underwent colonos-
copy under sedoanalgesia, the presence of IBS includes 
problems such as increased pre-procedural anxiety, in-
tra-procedural propofol requirement, and disruptive 
movements, to both the anesthesiologist and gastroen-
terologist. However, the increase in propofol consump-
tion is not related to the pre-procedural anxiety scores; 
however, it is probably caused by other mechanisms spe-
cific for IBS.
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